aps pharmacy semaglutide Injection | Starts at $149/mo Semaglutide shortage ends as FDA

Patients taking insulin or sulfonylureas with GLP-1 medications should be alert for hypoglycemia symptoms and contact their provider if these occur

Be a part of Elets Collaborative Initiatives

A gastric emptying study is often the most common test to diagnose gastroparesis

Withdrawal of Approval of 92 New Drug Applications and 49 Abbreviated New Drug Applications (2009)

When people stop taking GLP-1s, they often gain weight back as their appetite increases and cravings return

Ozempic Gallbladder Injuries and Side Effects Research indicates a connection between Ozempic and severe gastrointestinal events, specifically gallstones (cholelithiasis) and gallbladder inflammation (cholecystitis)